CN Patent

CN116710104A — 可通过定量吸入器递送的药物组合物

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2023-09-05 · 3y expired

What this patent protects

本公开涉及可通过定量吸入器递送的药物组合物。具体而言，该药物组合物包含悬浮介质、悬浮颗粒及活性剂。该药物组合物具有优异的稳定性和递送均一性，适用于肺部疾病的吸入治疗。

USPTO Abstract

本公开涉及可通过定量吸入器递送的药物组合物。具体而言，该药物组合物包含悬浮介质、悬浮颗粒及活性剂。该药物组合物具有优异的稳定性和递送均一性，适用于肺部疾病的吸入治疗。

Drugs covered by this patent

Patent Metadata

Patent number: CN116710104A
Jurisdiction: CN
Classification: —
Expires: 2023-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.